Corrective Eye Complex 15ml
R535,00
Stem Cell Technology
DermaFix Corrective Eye Complex combines Apple Stem Cell Technology with powerful Peptides and Hyaluronic Acid. Our unique Corrective Eye Complex prevents free-radical attacks, which leads to a chemical change called cross-linking. The combination of Apple Stem Cells, Hyaluronic Acid and Rice Peptides, found in our Corrective Eye Complex, increases the longevity of skin cells, resulting in a reduction of lines and wrinkles.
Key Ingredients: Apple Stem Cells, Hyaluronic Acid, Rice / Soy Peptides
In stock
Description
| Corrective Application | Start usage every alternate day for two weeks, progressing to daily application thereafter. Apply the DermaFix Corrective Eye Complex under the eye area and extend outwards towards the temples. Ensure thorough application for optimal results. This product may be used on the upper lip. |
|---|---|
| Key Ingredients | Apple Stem Cells: Malus Domestica. Scientists have found that a novel extract derived from the stem cells of a rare apple tree cultivated for its extraordinary longevity shows a tremendous ability to rejuvenate ageing skin.
Hyaluronic Acid: Proper hydration promotes cell communication and prevents TEWL (Trans-epidermal water loss). In connective tissue, Hyaluronic fills the space between the collagen and elastin fibres. Hyaluronic forms a thin, light-permeable viscous-elastic film on the surface of the skin. Natural Wrinkle Filler. Rice / Soy Peptides: Rice peptides are among the best formulations in maintaining skin elasticity. Rice peptides prevent the free radical attack which leads to a chemical change called cross-linking. |
| Benefits | The DermaFix Corrective Eye Complex works by stimulating epidermal regeneration with Stem Cell Technology. It is a quick-fill corrective that can be used as a quick fill for lines on the top lip. The Corrective Eye Complex increases lymphatic circulation, reducing puffiness and has a beneficial effect on capillary circulation. |
| Size | 15ml |
Reviews
There are no reviews yet.